Literature DB >> 20005492

CKD in HIV-infected patients other than HIV-associated nephropathy.

Ajay K Rachakonda1, Paul L Kimmel.   

Abstract

A spectrum of kidney diseases in HIV-infected patients has been reported both before and after the introduction of highly active antiretroviral therapy (HAART). Kidney syndromes affecting HIV-infected patients include CKD as well as proteinuria, nephrotic syndrome, and acute nephritic syndrome. Thrombotic microangiopathy should be considered in patients with kidney disease and typical clinical characteristics. As the HIV-infected population ages, there is increased concern regarding the incidence of vascular and metabolic disease, leading to an increased burden of CKD. Although HIV-associated nephropathy is still the major cause of nephrotic syndrome in HIV-infected patients, immune complex glomerulonephritis (ICGN) still comprises a substantial proportion of the disease burden, especially in people of European origin. Genetic investigations into the underpinnings of the various histologic expressions of HIV-associated kidney disease hold great promise. The single most important diagnostic test to differentiate various forms of kidney disease in HIV-infected patients is a kidney biopsy. The results of treating kidney disease in HIV-infected patients remain unclear, and properly designed randomized controlled trials of the treatment of ICGN with HAART and other approaches are desperately needed.

Entities:  

Mesh:

Year:  2010        PMID: 20005492     DOI: 10.1053/j.ackd.2009.09.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  6 in total

1.  Chronic kidney disease associated with perinatal HIV infection in children and adolescents.

Authors:  Murli U Purswani; Miriam C Chernoff; Charles D Mitchell; George R Seage; Gaston Zilleruelo; Carolyn Abitbol; Warren A Andiman; Kathleen A Kaiser; Hans Spiegel; James M Oleske
Journal:  Pediatr Nephrol       Date:  2012-02-26       Impact factor: 3.714

2.  Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.

Authors:  Mohamad Zaidan; François-Xavier Lescure; Isabelle Brochériou; Sarah Dettwiler; Jean-Baptiste Guiard-Schmid; Jérôme Pacanowski; Eric Rondeau; Gilles Pialoux; Pierre-Marie Girard; Pierre Ronco; Emmanuelle Plaisier
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 8.237

Review 3.  HIV-associated immune complex kidney disease.

Authors:  Ehsan Nobakht; Scott D Cohen; Avi Z Rosenberg; Paul L Kimmel
Journal:  Nat Rev Nephrol       Date:  2016-01-19       Impact factor: 28.314

Review 4.  Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients.

Authors:  Zygimantas C Alsauskas; Raj Kiran Medapalli; Michael J Ross
Journal:  Expert Opin Pharmacother       Date:  2011-01-21       Impact factor: 3.889

5.  Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.

Authors:  Ranjeeta Bahirwani; Burc Barin; Kim Olthoff; Peter Stock; Barbara Murphy; K Rajender Reddy
Journal:  Liver Transpl       Date:  2013-06       Impact factor: 5.799

6.  Notch4 activation aggravates NF-κB-mediated inflammation in HIV-1-associated nephropathy.

Authors:  Rajni Vaid Puri; Sireesha Yerrathota; Trisha Home; Jessica Y Idowu; V Praveen Chakravarthi; Christopher J Ward; Pravin C Singhal; Gregory B Vanden Heuvel; Timothy A Fields; Madhulika Sharma
Journal:  Dis Model Mech       Date:  2019-12-17       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.